Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%

Stock Information for Tonix Pharmaceuticals Holding Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tonix Pharmaceuticals Holding Corp.

Quipt Home Medical Announces Normal Course Issuer Bid
Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders
Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024
Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024
Quipt Home Medical Corp. Announces Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus
Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results Posting Revenue Growth of 59% and Adjusted EBITDA Growth of 73%
Quipt Home Medical Corp. to Announce Fourth Quarter and Full Year 2023 Financial Results on December 18, 2023
Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.